1.
Artur C. Fassoni, Christoph Baldow, Ingo Roeder, Ingmar Glauche. Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data. haematol [Internet]. 2018Nov.1 [cited 2021Dec.2];103(11):1825-34. Available from: https://haematologica.org/article/view/8660